GlassScriptPhysician profile
Savannah Stockton
NPI 1639795529
$6,399.91
in general payments reported to CMS, 2019-2025
18 companies · $3,497 in 2025
The $3,497 reported for 2025 was more than what 94% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $376 · 2023: $1,754 · 2024: $595 · 2025: $3,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,984 · Food and Beverage: $2,861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,984.10 |
| Food and Beverage | $2,861.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $4,345.15 | 2023-2025 | Inspire |
| Medtronic, INC. | $318.36 | 2021-2023 | Stealthstation S8 Platform |
| Kerecis Limited | $303.09 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $218.28 | 2022-2023 | Integra, Integra Duo, Instruments-Orthopedic |
| Axogen | $170.61 | 2025 | |
| Depuy Synthes Sales INC. | $145.99 | 2024-2025 | Trumatch, Matrixcombo |
| Ambu INC. | $135.33 | 2021 | |
| Polynovo North America LLC | $134.20 | 2024 | Novosorb Btm |
| Acera Surgical, INC. | $129.56 | 2023 | Restrata Wound Matrix |
| Stryker Corporation | $116.47 | 2023-2025 | Duramatrix, Hydroset, Adherus Autospray Dural Sealant |
| Solventum Corporation | $114.13 | 2024 | V.A.C. Granufoam, V.A.C.Instill |
| Regeneron Healthcare Solutions, INC. | $72.14 | 2023-2025 | Dupixent |
| Cochlear Americas | $63.50 | 2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Glaxosmithkline, LLC. | $49.05 | 2023-2025 | Nucala |
| Cumberland Pharmaceuticals, INC. | $23.87 | 2025 | Caldolor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $22.92 | 2021 | |
| Fisher & Paykel Healthcare INC | $22.75 | 2023 | Fisher & Paykel Healthcare |
| Abbvie INC. | $14.51 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savannah Stockton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.